Cresco Labs (FRA:6CQ) Cyclically Adjusted PB Ratio: (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6CQ Cresco Labs Inc FRA:6CQ
44 GF Score
Price €0.58
GF Value €0.78
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cresco Labs Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cresco Labs  (FRA:6CQ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cresco Labs Cyclically Adjusted PB Ratio Related Terms


Cresco Labs Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Cresco Labs's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Cyclically Adjusted PB Ratio Chart

Cresco Labs Annual Data
Trend Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cresco Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:6CQ vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted PB Ratio falls into.


FRA:6CQ
44GF Score
Cresco Labs Inc FRA:6CQ
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cresco Labs Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cresco Labs's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Cresco Labs's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.785/330.2130*330.2130
=0.785

Current CPI (Mar. 2026) = 330.2130.

Cresco Labs Quarterly Data

Book Value per Share CPI Adj_Book
201604 -21.743 239.261 -30.008
201607 -21.943 240.628 -30.112
201610 -21.629 241.729 -29.546
201701 -24.743 242.839 -33.646
201704 -23.943 244.524 -32.333
201707 -24.771 244.786 -33.416
201710 -23.914 246.663 -32.014
201801 -24.914 247.867 -33.191
201804 -24.286 250.546 -32.008
201807 -22.343 252.006 -29.277
201810 -0.212 252.885 -0.277
201903 0.953 254.202 1.238
201906 0.911 256.143 1.174
201909 1.207 256.759 1.552
201912 1.280 256.974 1.645
202003 2.745 258.115 3.512
202006 2.550 257.797 3.266
202009 2.397 260.280 3.041
202012 1.741 260.474 2.207
202103 2.117 264.877 2.639
202106 2.738 271.696 3.328
202109 2.080 274.310 2.504
202112 2.300 278.802 2.724
202203 2.251 287.504 2.585
202206 2.530 296.311 2.819
202209 2.648 296.808 2.946
202212 1.965 296.797 2.186
202303 1.879 301.836 2.056
202306 1.711 305.109 1.852
202309 1.405 307.789 1.507
202312 1.365 306.746 1.469
202403 1.353 312.332 1.430
202406 1.250 314.175 1.314
202409 1.184 315.301 1.240
202412 1.301 315.605 1.361
202503 1.212 319.799 1.251
202506 1.084 322.561 1.110
202509 1.021 324.800 1.038
202512 0.809 324.054 0.824
202603 0.785 330.213 0.785

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cresco Labs (FRA:6CQ) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of €0.58 is trading 25.4% below its estimated GF Value™ of €0.78. GuruFocus considers Cresco Labs to be Modestly Undervalued.

Key valuation signals for FRA:6CQ:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €0.78 vs. price of €0.58 (25.4% below fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the FRA:6CQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cresco Labs Business Description

Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
44GF Score

Get the complete analysis for FRA:6CQ

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.58
Price
€0.78
GF Value